Quantitative Mass Spectrometry Imaging of Amino Acids Enabled by Pyridinium Salt MALDI Probe.
1/5 보강
Amino acids (AAs) are closely linked to various diseases.
APA
Zhou H, Yuan J, et al. (2025). Quantitative Mass Spectrometry Imaging of Amino Acids Enabled by Pyridinium Salt MALDI Probe.. Analytical chemistry, 97(43), 23793-23801. https://doi.org/10.1021/acs.analchem.5c01847
MLA
Zhou H, et al.. "Quantitative Mass Spectrometry Imaging of Amino Acids Enabled by Pyridinium Salt MALDI Probe.." Analytical chemistry, vol. 97, no. 43, 2025, pp. 23793-23801.
PMID
41129406 ↗
Abstract 한글 요약
Amino acids (AAs) are closely linked to various diseases. Investigating their spatial distribution and content differences can provide deeper insights into specific disease mechanisms. Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) enables spatial visualization of biomolecules, but conventional matrices introduce significant background interference that limits the detection of small molecules such as AAs. On-tissue chemical derivatization (OTCD) using permanently charged pyridinium probes significantly enhances the detection sensitivity of poorly ionizable compounds like AAs, allowing for their spatial mapping. However, current quantitative mass spectrometry imaging (QMSI) strategies for AAs using conventional matrix remain limited, highlighting the urgent need for the development of a widely applicable absolute quantification method for AAs that integrates OTCD. In this study, a series of pyridinium salt-based MALDI-MS probes were designed and characterized, leading to the identification of an efficient candidate, 1-(4-(((2,5-dioxopyrrolidin-1-yl)oxy)carbonyl)-2-methylphenyl)-2,4,6-triphenylpyridin-1-ium tetrafluoroborate (DCMT-4FB). This probe was then combined with deuterium-labeled internal standard to establish calibration curve, and its linear correction capability was validated, demonstrating strong correlation coefficients. Furthermore, a novel quantitative endogenous substance spraying approach was employed to perform absolute quantification MSI analysis of AAs (leucine and isoleucine) in different regions of human hepatocellular carcinoma (HCC) tissue sections. Finally, by cospraying the DCMT-4FB probe with its deuterium-labeled isotope analog, DCMT--4FB, the spatial distribution of AAs and other metabolites within HCC tissues was rapidly obtained, providing valuable insights for clinical research. This study highlights the superior AAs quantification capability of the DCMT-4FB probe and offers new perspectives for probe development and quantitative analysis of endogenous metabolites.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- A clinic-responder-derived defined microbial consortium enhances anti-PD-1 immunotherapy efficacy in mice.
- Global and National Burden of Chronic Obstructive Pulmonary Disease and Tracheal, Bronchus, and Lung Cancer From 1990 to 2021: Comorbidity Burden Analysis Based on the Global Burden of Disease Study 2021.
- Izalontamab Brengitecan in Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations Outside of Classical Mutations: A Phase Ib Study.
- MTA1 upregulation enhances stemness and chemoresistance of gastric cancer cells.
- Symptom Cluster Trajectories of Cough, Shortness of Breath, and Disturbed Sleep in Patients Undergoing Lung Cancer Surgery: A Longitudinal Study.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Association between metabolic dysfunction-associated steatotic liver disease and breast cancer risk in Korean women: a nationwide population-based cohort study.
- LCMS-Net: Deep Learning for Raw High Resolution Mass Spectrometry Data Applied to Forensic Cause-of-Death Screening.
- Lateral Tension Upper Body Lift: "Zip-Shark" Technique as Novel Procedure.
- Determination of hair cortisol by liquid chromatography coupled to mass spectrometry (LC-MS/MS) as biomarker of chronic stress and application to academic students.
- The Centers for Medicare and Medicaid Services and others misunderstand stool testing for colorectal cancer.